Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS)
INR 66.86
(-0.9%)
INR 66.86
(-0.9%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 666.26 Million INR | 5.44% |
| 2022 | 631.88 Million INR | 2.58% |
| 2021 | 615.96 Million INR | 4.0% |
| 2020 | 592.29 Million INR | 1.34% |
| 2019 | 584.43 Million INR | 3.17% |
| 2018 | 566.49 Million INR | -2.68% |
| 2017 | 582.11 Million INR | 6.23% |
| 2016 | 547.95 Million INR | -0.06% |
| 2015 | 548.28 Million INR | -2.81% |
| 2014 | 564.15 Million INR | -3.65% |
| 2013 | 585.54 Million INR | 2.91% |
| 2012 | 568.95 Million INR | 1.51% |
| 2011 | 560.48 Million INR | -10.48% |
| 2010 | 626.13 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 666.26 Million INR | 5.44% |
| 2023 Q2 | 668.14 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 666.26 Million INR | 0.0% |
| 2022 FY | 631.88 Million INR | 2.58% |
| 2022 Q2 | 639.4 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 631.88 Million INR | 0.0% |
| 2021 Q4 | 615.96 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 615.96 Million INR | 4.0% |
| 2021 Q2 | 615.61 Million INR | 0.0% |
| 2020 Q2 | 574.33 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 592.29 Million INR | 0.0% |
| 2020 FY | 592.29 Million INR | 1.34% |
| 2019 FY | 584.43 Million INR | 3.17% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 590.28 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 584.43 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 566.49 Million INR | 0.0% |
| 2018 Q2 | 584.6 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 566.49 Million INR | -2.68% |
| 2017 Q4 | 582.11 Million INR | 1.29% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 582.11 Million INR | 6.23% |
| 2017 Q2 | 580.31 Million INR | 0.0% |
| 2017 Q3 | 574.72 Million INR | -0.96% |
| 2016 Q4 | 547.95 Million INR | 0.0% |
| 2016 Q2 | 569.31 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 547.95 Million INR | -0.06% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 548.28 Million INR | -2.81% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 548.28 Million INR | 0.0% |
| 2015 Q2 | 563.65 Million INR | 0.0% |
| 2014 Q4 | 564.15 Million INR | 0.0% |
| 2014 FY | 564.15 Million INR | -3.65% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 594.16 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 574.08 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 585.54 Million INR | 2.91% |
| 2013 Q4 | 585.54 Million INR | 0.0% |
| 2012 FY | 568.95 Million INR | 1.51% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 573.7 Million INR | 0.0% |
| 2012 Q4 | 568.95 Million INR | 0.0% |
| 2011 Q4 | 560.48 Million INR | 0.0% |
| 2011 FY | 560.48 Million INR | -10.48% |
| 2010 Q4 | 626.13 Million INR | 0.0% |
| 2010 FY | 626.13 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 167.53 Billion INR | 99.602% |
| Artemis Medicare Services Limited | 9.71 Billion INR | 93.142% |
| Aster DM Healthcare Limited | 179.91 Billion INR | 99.63% |
| Fortis Healthcare Limited | 132.88 Billion INR | 99.499% |
| HealthCare Global Enterprises Limited | 27.07 Billion INR | 97.539% |
| Indraprastha Medical Corporation Limited | 7.23 Billion INR | 90.788% |
| Krishna Institute of Medical Sciences Limited | 38.52 Billion INR | 98.27% |
| Max Healthcare Institute Limited | 119.99 Billion INR | 99.445% |
| Max India Limited | 6.84 Billion INR | 90.264% |
| Global Health Limited | 43.04 Billion INR | 98.452% |
| Narayana Hrudayalaya Limited | 56.24 Billion INR | 98.815% |
| Rainbow Children's Medicare Limited | 21.7 Billion INR | 96.93% |
| Shalby Limited | 16.07 Billion INR | 95.855% |